Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

I. B. Runnebaum, S. Wang-Gohrke, D. Vesprini, R. Kreienberg, H. Lynch, R. Moslehi, P. Ghadirian, B. Weber, A. K. Godwin, H. Risch, J. Garber, C. Lerman, O. I. Olopade, W. D. Foulkes, B. Karlan, E. Warner, B. Rosen, T. Rebbeck, P. Tonin, M. P. DubéD. G. Kieback, S. A. Narod

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint Dive into the research topics of 'Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives'. Together they form a unique fingerprint.

Medicine & Life Sciences